Europe's No. 1 Natural Weight-Loss Formula Lends Helping Hand to Combat Holiday Season Excesses in the U.S.

Weight-loss battle gains a powerful, natural ally in I-REMOVE

Washington, D.C. January 12, 2018—After a "calorie-rich" holiday season, it’s not uncommon for many people to see some extra, unwanted pounds on the scale. Add to this well-intentioned New Year's resolutions and frustration with hard-to-maintain healthy lifestyle choices, it can all seem like a never-ending battle.

Fortunately, help is at hand.

I-REMOVE, Europe's number one-selling weight-loss aid, is now available in the United States. It is on sale at and more than 7,700 Walgreens stores nationwide.

I-REMOVE is a clinically tested, plant-based, weight-loss supplement that helps reduce the calorie absorption from dietary fats. Combined with healthy eating and moderate lifestyle changes, it can help boost weight loss by up to 3X more than healthy eating alone.1 Additionally, clinical tests plus an 11-year sales history show I-REMOVE is easily tolerated and does not cause undesirable side effects.1,3

The supplement is powered by Litramine, a patented, natural-fiber complex, which has been shown in clinical tests to bind to fat molecules in food creating fat-fiber complexes too large to be absorbed by the intestine. The body then, naturally and gently, eliminates the fat (through the GI tract).3 Additionally, as it is fiber based, I-REMOVE, has been shown to promote a feeling of fullness.2

This dual action, combined with excellent tolerability, helps enhance weight loss, and paves the way for a healthier, balanced lifestyle that people can maintain long-term. A 24-week clinical study showed that 92% of participants taking Litramine were able to maintain or increase weight loss versus only 25% in the placebo group.2

Speaking in Washington, D.C. today, Joshua Tully, vice president of sales for I-REMOVE, said: “I-REMOVE offers a helping hand for those wishing to break free from failed attempts to lose weight and acts as a powerful, natural ally to help them reach and maintain their optimum weight to become their best selves.”

For more media information, please contact


I-REMOVE, the number-one-selling weight-loss formula in Europe, is now available in the U.S. Clinically tested to help people lose weight and maintain weight loss, it is shown to deliver up to three times more weight loss versus dieting alone. I-REMOVE can help people break the weight loss/regain cycle by the dual action of fat binding for decreased fat absorption and increased satiety. Together, these result in a reduced calorie absorption, without undesirable side effects.1,2 In combination with a healthy lifestyle, I-REMOVE has been shown to effectively help boost weight loss efforts in people 18 years of age and older who are overweight or slightly obese.1

I-REMOVE can be easily incorporated into a busy schedule but must be part of a healthy lifestyle, which includes healthy food choices and moving more. This doesn’t mean going on drastic diets of less than 800 calories per day or spending countless hours in the gym, it means making healthier eating decisions—even if the occasional slip up happens—and incorporating more movement into a typical day such as 30 minutes of walking. While diets have a beginning and an end, I-REMOVE is meant to help people adopt a healthy lifestyle that they can sustain over the long-term.

About Zaluvida, the manufacturer of I-REMOVE

Zaluvida is a globally operating life science group that endeavors to rapidly develop solutions for some of the biggest challenges in healthcare. The company is led from its corporate offices in Switzerland and has branches in Germany, Wales, the Netherlands, the U.S., and Malaysia. By making use of unique bioactive compounds with pharma-grade efficacy, Zaluvida is a pioneer in therapies and technologies for obesity, antibiotic resistance, and the reduction of greenhouse gas emissions. Our team is united by the desire to use visionary biotech innovations to support as many people as possible in shaping a better future for themselves.

For further information visit: